Table 4.
Median (interquartile range) intrapatient CV (%) for the various albuminuria measures in the overall population and in gender-specific subgroups
| Parameter | UAE | UAC | ACR | Creatinine |
|---|---|---|---|---|
| Overall (n = 241) | ||||
| 24-h urine collection | 19.0 (10.9 to 33.2) | 26.2 (17.8 to 42.9) | 19.2 (10.9 to 32.6) | 9.3 (4.8 to 18.4) |
| FMV | 30.9 (19.4 to 47.8)a | 19.1 (11.6 to 28.4) | 23.5 (13.8 to 66.7) | |
| SUS | 40.9 (27.8 to 70.2)a | 35.8 (17.6 to 55.6)a | 31.3 (19.1 to 56.1) | |
| Men (n = 124) | ||||
| 24-h urine collection | 21.4 (11.5 to 33.6) | 30.1 (20.2 to 46.7) | 19.2 (11.1 to 36.0) | 10.0 (4.8 to 20.3) |
| FMV | 29.2 (18.2 to 46.1)a | 18.0 (10.4 to 27.4)a | 22.7 (13.1 to 31.8) | |
| SUS | 38.9 (27.7 to 65.5)a | 30.7 (15.7 to 53.6)a | 31.2 (19.8 to 50.5) | |
| Women (n = 117) | ||||
| 24-h urine collection | 18.2 (9.9 to 31.8) | 22.2 (14.3 to 42.3) | 18.9 (9.8 to 30.4) | 7.7 (4.9 to 14.7) |
| FMV | 32.4 (21.1 to 48.7)a | 19.4 (12.0 to 30.0) | 25.3 (14.2 to 34.9) | |
| SUS | 42.6 (27.8 to 82.1)a | 36.6 (22.2 to 62.2)a | 33.4 (17.2 to 64.4) |
a
P ≤ 0.05 versus intraindividual CV for 24-h UAE.